{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:07:47Z","timestamp":1784887667485,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005296","name":"Universit\u00e4tsklinikum Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005296","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early identification and treatment of patients with severe infections or sepsis remains challenging, and suitable biomarkers are lacking. This prospective exploratory pilot study aimed to evaluate the potential of point-of-care bioactive adrenomedullin (POC bio-ADM) in predicting bacteremia in patients presenting to the emergency department (ED) with suspected severe infections. Secondary objectives included its association with any infection, in-hospital mortality, intensive care unit (ICU) admission, and ICU length of stay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective exploratory pilot cohort study, adult patients presenting to the ED of a German university hospital between December 2022 and September 2023 were enrolled. POC bio-ADM levels were analyzed using univariate and multivariable binary logistic regression and compared to established sepsis biomarkers (PCT, CRP, lactate).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>47 patients were included in the final analysis. POC bio-ADM was positive (&gt;\u200945 pg\/ml) in 38.3% (95% CI: 25.8\u201352.6%). Bacteremia was found in 34.0% (95% CI: 22.2\u201348.3%), and 78.7% (95% CI: 65.1\u201388.8%) had an infection. Positive POC bio-ADM was associated with significantly higher rates of bacteremia (55.6% vs. 20.7%). In the multivariable analysis, a positive POC bio-ADM was associated with an odds ratio (OR) of 5.318 (95% CI: 1.217\u201323.243) for bacteremia. Attributable in-hospital mortality was higher in patients with elevated POC bio-ADM (44.4% vs. 3.6%; OR: 21.6, 95% CI: 2.4-195.3).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This small, single-centre pilot exploratory study suggests that POC bio-ADM may help identify ED patients with suspected severe infection at increased risk of bacteremia and in-hospital mortality; these findings are hypothesis-generating and require confirmation in larger cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-12951-1","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T16:02:51Z","timestamp":1772294571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bioactive adrenomedullin as a point-of-care biomarker in emergency department patients with suspected severe infections: an exploratory analysis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0950-4307","authenticated-orcid":false,"given":"Constantin","family":"Maier-Stocker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Hupf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillena","family":"Zinsser-Krys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Hanses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"12951_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395:200\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7.","journal-title":"Lancet"},{"key":"12951_CR2","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49:e1063\u2013143. https:\/\/doi.org\/10.1097\/CCM.0000000000005337.","journal-title":"Crit Care Med"},{"key":"12951_CR3","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*. Crit Care Med. 2006;34:1589\u201396. https:\/\/doi.org\/10.1097\/01.CCM.0000217961.75225.E9.","journal-title":"Crit Care Med"},{"key":"12951_CR4","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s11739-021-02735-7","volume":"16","author":"F Gavelli","year":"2021","unstructured":"Gavelli F, Castello LM, Avanzi GC. Management of sepsis and septic shock in the emergency department. Intern Emerg Med. 2021;16:1649\u201361. https:\/\/doi.org\/10.1007\/s11739-021-02735-7.","journal-title":"Intern Emerg Med"},{"key":"12951_CR5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/CCM.0000000000004225","volume":"48","author":"TG Buchman","year":"2020","unstructured":"Buchman TG, Simpson SQ, Sciarretta KL, et al. Sepsis Among Medicare Beneficiaries: 3. The Methods, Models, and Forecasts of Sepsis, 2012\u20132018*. Crit Care Med. 2020;48:302\u201318. https:\/\/doi.org\/10.1097\/CCM.0000000000004225.","journal-title":"Crit Care Med"},{"key":"12951_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13054-021-03862-5","volume":"26","author":"T Barichello","year":"2022","unstructured":"Barichello T, Generoso JS, Singer M, Dal-Pizzol F. Biomarkers for sepsis: more than just fever and leukocytosis\u2014a narrative review. Crit Care. 2022;26:14. https:\/\/doi.org\/10.1186\/s13054-021-03862-5.","journal-title":"Crit Care"},{"key":"12951_CR7","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/CCM.0000000000006216","volume":"52","author":"M Bolanaki","year":"2024","unstructured":"Bolanaki M, Winning J, Slagman A, et al. Biomarkers Improve Diagnostics of Sepsis in Adult Patients With Suspected Organ Dysfunction Based on the Quick Sepsis-Related Organ Failure Assessment (qSOFA) Score in the Emergency Department*. Crit Care Med. 2024;52:887\u201399. https:\/\/doi.org\/10.1097\/CCM.0000000000006216.","journal-title":"Crit Care Med"},{"key":"12951_CR8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.5005\/jp-journals-10071-23669","volume":"24","author":"AK Ajith Kumar","year":"2020","unstructured":"Ajith Kumar AK. Adrenomedullin in Sepsis: Finally, a Friend or an Enemy? Indian J Crit Care Med. 2020;24:1151\u20133. https:\/\/doi.org\/10.5005\/jp-journals-10071-23669.","journal-title":"Indian J Crit Care Med"},{"key":"12951_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/SHK.0000000000001103","volume":"50","author":"C Geven","year":"2018","unstructured":"Geven C, Bergmann A, Kox M, Pickkers P. Vascular Effects of Adrenomedullin and the Anti-Adrenomedullin Antibody Adrecizumab in Sepsis. Shock. 2018;50:132\u201340. https:\/\/doi.org\/10.1097\/SHK.0000000000001103.","journal-title":"Shock"},{"key":"12951_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fimmu.2018.00292","volume":"9","author":"C Geven","year":"2018","unstructured":"Geven C, Kox M, Pickkers P. Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis. Front Immunol. 2018;9:292. https:\/\/doi.org\/10.3389\/fimmu.2018.00292.","journal-title":"Front Immunol"},{"key":"12951_CR11","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s13054-020-03351-1","volume":"24","author":"OHM Lundberg","year":"2020","unstructured":"Lundberg OHM, Lengquist M, Sp\u00e5ngfors M, et al. Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness. Crit Care. 2020;24:636. https:\/\/doi.org\/10.1186\/s13054-020-03351-1.","journal-title":"Crit Care"},{"key":"12951_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3343\/alm.2019.39.5.454","volume":"39","author":"H Kim","year":"2019","unstructured":"Kim H, Hur M, Struck J, et al. Circulating Biologically Active Adrenomedullin Predicts Organ Failure and Mortality in Sepsis. Ann Lab Med. 2019;39:454\u201363. https:\/\/doi.org\/10.3343\/alm.2019.39.5.454.","journal-title":"Ann Lab Med"},{"key":"12951_CR13","doi-asserted-by":"publisher","first-page":"e0267497","DOI":"10.1371\/journal.pone.0267497","volume":"17","author":"OHM Lundberg","year":"2022","unstructured":"Lundberg OHM, Rosenqvist M, Bronton K, et al. Bioactive adrenomedullin in sepsis patients in the emergency department is associated with mortality, organ failure and admission to intensive care. PLoS ONE. 2022;17:e0267497. https:\/\/doi.org\/10.1371\/journal.pone.0267497.","journal-title":"PLoS ONE"},{"key":"12951_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s13054-018-2243-2","volume":"22","author":"A Mebazaa","year":"2018","unstructured":"Mebazaa A, Geven C, Hollinger A, et al. Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study. Crit Care. 2018;22:354. https:\/\/doi.org\/10.1186\/s13054-018-2243-2.","journal-title":"Crit Care"},{"key":"12951_CR15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.chest.2017.03.035","volume":"152","author":"P Caironi","year":"2017","unstructured":"Caironi P, Latini R, Struck J, et al. Circulating Biologically Active Adrenomedullin (bio-ADM) Predicts Hemodynamic Support Requirement and Mortality During Sepsis. Chest. 2017;152:312\u201320. https:\/\/doi.org\/10.1016\/j.chest.2017.03.035.","journal-title":"Chest"},{"key":"12951_CR16","doi-asserted-by":"publisher","first-page":"e14225","DOI":"10.1111\/eci.14225","volume":"54","author":"E Valeriani","year":"2024","unstructured":"Valeriani E, Falletta A, Pastori D, et al. Midregional-proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta\u2010analysis. Eur J Clin Invest. 2024;54:e14225. https:\/\/doi.org\/10.1111\/eci.14225.","journal-title":"Eur J Clin Invest"},{"key":"12951_CR17","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","volume":"351","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527. https:\/\/doi.org\/10.1136\/bmj.h5527.","journal-title":"BMJ"},{"key":"12951_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/jcm8020222","volume":"8","author":"SY Hwang","year":"2019","unstructured":"Hwang SY, Shin J, Jo IJ, et al. Delayed Antibiotic Therapy and Organ Dysfunction in Critically Ill Septic Patients in the Emergency Department. JCM. 2019;8:222. https:\/\/doi.org\/10.3390\/jcm8020222.","journal-title":"JCM"},{"key":"12951_CR19","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/CCM.0b013e3181cc4824","volume":"38","author":"DF Gaieski","year":"2010","unstructured":"Gaieski DF, Mikkelsen ME, Band RA, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department*. Crit Care Med. 2010;38:1045\u201353. https:\/\/doi.org\/10.1097\/CCM.0b013e3181cc4824.","journal-title":"Crit Care Med"},{"key":"12951_CR20","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","volume":"196","author":"VX Liu","year":"2017","unstructured":"Liu VX, Fielding-Singh V, Greene JD, et al. The Timing of Early Antibiotics and Hospital Mortality in Sepsis. Am J Respir Crit Care Med. 2017;196:856\u201363. https:\/\/doi.org\/10.1164\/rccm.201609-1848OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"12951_CR21","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gesten F, Prescott HC, et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. N Engl J Med. 2017;376:2235\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1703058.","journal-title":"N Engl J Med"},{"key":"12951_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.clinthera.2016.12.003","volume":"39","author":"ANB Johnston","year":"2017","unstructured":"Johnston ANB, Park J, Doi SA, et al. Effect of Immediate Administration of Antibiotics in Patients With Sepsis in Tertiary Care: A Systematic Review and Meta-analysis. Clin Ther. 2017;39:190\u2013e2026. https:\/\/doi.org\/10.1016\/j.clinthera.2016.12.003.","journal-title":"Clin Ther"},{"key":"12951_CR23","doi-asserted-by":"publisher","first-page":"R34","DOI":"10.1186\/cc13731","volume":"18","author":"R Marino","year":"2014","unstructured":"Marino R, Struck J, Maisel AS, et al. Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis. Crit Care. 2014;18:R34. https:\/\/doi.org\/10.1186\/cc13731.","journal-title":"Crit Care"},{"key":"12951_CR24","doi-asserted-by":"publisher","first-page":"R816","DOI":"10.1186\/cc3885","volume":"9","author":"M Christ-Crain","year":"2005","unstructured":"Christ-Crain M, Morgenthaler NG, Struck J, et al. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care. 2005;9:R816\u2013824. https:\/\/doi.org\/10.1186\/cc3885.","journal-title":"Crit Care"},{"key":"12951_CR25","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/10623320701678326","volume":"14","author":"P Schuetz","year":"2007","unstructured":"Schuetz P, Christ-Crain M, Morgenthaler NG, et al. Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium. 2007;14:345\u201351. https:\/\/doi.org\/10.1080\/10623320701678326.","journal-title":"Endothelium"},{"key":"12951_CR26","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00134-009-1610-5","volume":"35","author":"C Guignant","year":"2009","unstructured":"Guignant C, Voirin N, Venet F, et al. Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients. Intensive Care Med. 2009;35:1859\u201367. https:\/\/doi.org\/10.1007\/s00134-009-1610-5.","journal-title":"Intensive Care Med"},{"key":"12951_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13054-016-1361-y","volume":"20","author":"OHM Lundberg","year":"2016","unstructured":"Lundberg OHM, Bergenzaun L, Ryd\u00e9n J, et al. Adrenomedullin and endothelin-1 are associated with myocardial injury and death in septic shock patients. Crit Care. 2016;20:178. https:\/\/doi.org\/10.1186\/s13054-016-1361-y.","journal-title":"Crit Care"},{"key":"12951_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","volume":"24","author":"M Bauer","year":"2020","unstructured":"Bauer M, Gerlach H, Vogelmann T, et al. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019\u2014 results from a systematic review and meta-analysis. Crit Care. 2020;24:239. https:\/\/doi.org\/10.1186\/s13054-020-02950-2.","journal-title":"Crit Care"},{"key":"12951_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10049-022-01078-w","volume":"28","author":"W Bauer","year":"2025","unstructured":"Bauer W, Galtung N, Von Wunsch-Rolshoven Teruel I, et al. Screening auf Sepsis in der Notfallmedizin \u2013 qSOFA ist uns nicht genug. Notfall Rettungsmed. 2025;28:21\u20138. https:\/\/doi.org\/10.1007\/s10049-022-01078-w.","journal-title":"Notfall Rettungsmed"},{"key":"12951_CR30","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","volume":"41","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580\u2013637. https:\/\/doi.org\/10.1097\/CCM.0b013e31827e83af.","journal-title":"Crit Care Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12951-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12951-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12951-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:06:38Z","timestamp":1781636798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12951-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12951"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12951-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. The study was approved by the ethic committee of the University Regensburg (Vote # 23-3397-101). Informed consent was obtained from all participants or their legal representatives prior to inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"715"}}